Drug Truths – Dispelling the Myths About Pharma R D

John L. LaMattina, PhD , retired as president of Pfizer Global Research and Development in 2007 where he managed more than 13,000 scientists and support professionals in the United States, Europe, and Asia. Dr. LaMattina has received numerous awards including an Honorary Doctor of Science degree from the University of New Hampshire.

Acknowledgments. Introduction. PART 1: A MATTER OF THE HEART. Chapter 1: Cholesterol Drugs Are Unnecessary. Chapter 2: Industry is More Interested in "Me-Too" Drugs Than in Innovation. Chapter 3: It Takes Industry Too Long to Discover New Drugs. PART 2: THE ROLE OF PHARMACEUTICAL R&D IN HEALTHCARE. Chapter 4: Drugs Are Discovered by Academia. Chapter 5: New Medicines Add Costs but Little Benefit. Chapter 6: Big Pharma Has Failed and Should Learn From Biotech Success. PART 3: THE PROFIT MOTIVE. Chapter 7: The Industry Invents Diseases. Chapter 8: New Drugs Are Less Safe Than Traditional Medicines. Chapter 9: Industry Spends More on Advertising Than R&D. Chapter 10: Industry Does Not Care About Diseases of the Developing World. PART 4: THE FUTURE. Chapter 11: Big Pharma's Day Has Passed. Chapter 12: Final Reflections. References. Index.